CD44 and breast carcinoma: The objective of the present study was to examine whether the fusion of TAMs and breast cancer cells results in the genetic reprogramming and generation of CD44+CD24−/low breast cancer stem cells (BCSCs), which may contribute to metastasis and relapse [27].